Dexco (DXCO3) Aperçu de l'action
Dexco S.A. et ses filiales produisent et vendent des panneaux de bois au Brésil et à l'étranger. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 3/6 |
| Croissance future | 3/6 |
| Performances passées | 1/6 |
| Santé financière | 1/6 |
| Dividendes | 0/6 |
Récompenses
Analyse des risques
DXCO3 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Materials opportunity
ST
Fair Value from
CA$5.0769.0% sous-évalué décote intrinsèque
An Undervalued 3.3Moz Gold Project in Canada
Key takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.
Read full narrativeDexco S.A. Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | R$5.77 |
| Plus haut sur 52 semaines | R$6.22 |
| Plus bas sur 52 semaines | R$4.43 |
| Bêta | 0.49 |
| Variation sur 1 mois | 6.26% |
| Variation sur 3 mois | 0.52% |
| Variation sur 1 an | 23.80% |
| Variation sur 3 ans | -12.43% |
| Variation sur 5 ans | -63.66% |
| Évolution depuis l'introduction en bourse | -13.33% |
Nouvelles et mises à jour récentes
Mise à jour de l'analyse • May 02
DXCO3: Future Stock Split Will Support More Attractive Multiple Repricing Outlook
Analysts have raised their price target on Dexco from approximately R$7.16 to about R$7.28, citing updated assumptions regarding the discount rate, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value: R$7.16 to R$7.28, representing a small upward adjustment in the modelled target price range.
Mise à jour de l'analyse • Apr 18
DXCO3: Higher Revenue Outlook And Richer Future P/E Will Support Upside
Analysts have raised their valuation of Dexco, increasing the fair value estimate from R$8.70 to R$9.00. The change reflects updated assumptions that include higher revenue growth expectations, a lower discount rate and a richer future P/E multiple, partly offset by a lower projected profit margin.Mise à jour de l'analyse • Apr 04
DXCO3: Future Stock Split Will Support A More Attractive Repricing Outlook
Analysts have slightly adjusted their R$ price target on Dexco, citing updated assumptions that combine a different fair value estimate with changes to revenue growth, profit margin expectations and a higher future P/E multiple. Valuation Changes Fair Value: R$7.22 in the previous model compared with R$7.16 in the updated assumptions.Recent updates
Mise à jour de l'analyse • May 02
DXCO3: Future Stock Split Will Support More Attractive Multiple Repricing Outlook
Analysts have raised their price target on Dexco from approximately R$7.16 to about R$7.28, citing updated assumptions regarding the discount rate, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value: R$7.16 to R$7.28, representing a small upward adjustment in the modelled target price range.Mise à jour de l'analyse • Apr 18
DXCO3: Higher Revenue Outlook And Richer Future P/E Will Support Upside
Analysts have raised their valuation of Dexco, increasing the fair value estimate from R$8.70 to R$9.00. The change reflects updated assumptions that include higher revenue growth expectations, a lower discount rate and a richer future P/E multiple, partly offset by a lower projected profit margin.Mise à jour de l'analyse • Apr 04
DXCO3: Future Stock Split Will Support A More Attractive Repricing Outlook
Analysts have slightly adjusted their R$ price target on Dexco, citing updated assumptions that combine a different fair value estimate with changes to revenue growth, profit margin expectations and a higher future P/E multiple. Valuation Changes Fair Value: R$7.22 in the previous model compared with R$7.16 in the updated assumptions.
Mise à jour de l'analyse • Mar 21
DXCO3: Planned Stock Split And Margin Outlook Will Support Future Upside
Analysts have kept their R$ fair value estimate for Dexco steady at R$5.36. Updated assumptions reflect a slightly higher discount rate, a marginally lower revenue growth outlook, a modestly stronger profit margin, and a similar future P/E expectation.Mise à jour de l'analyse • Mar 06
DXCO3: Planned Stock Split Will Support Positive Long Term Outlook
Analysts have revised their R$ price target for Dexco slightly, with the change grounded in updated assumptions that include a different discount rate, adjusted revenue growth and profit margin expectations, and a revised future P/E multiple. What's in the News Dexco plans a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).Mise à jour de l'analyse • Feb 20
DXCO3: Future Stock Split Will Support A More Attractive Share Repricing
Analysts have trimmed their R$ price target for Dexco, reflecting a slightly lower fair value estimate alongside updated assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News Dexco announced a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).Mise à jour de l'analyse • Feb 06
DXCO3: Stock Split And Conservative Earnings Profile Will Support Future Upside
Analysts have reduced their fair value estimate for Dexco from about $8.81 to $8.70 per share. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E, which collectively indicate a more conservative earnings profile than previously estimated.Mise à jour de l'analyse • Jan 23
DXCO3: Future Split And Revised Assumptions Will Shape Balanced Outlook
Analysts have reduced their fair value estimate for Dexco from US$6.00 to US$5.36, citing updated assumptions for revenue growth, profit margins, the discount rate, and a lower future P/E multiple. What's in the News Dexco has announced a stock split or significant stock dividend with a 1.12 to 1 ratio, scheduled for December 26, 2025 (Key Developments).Article d'analyse • Jan 23
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Mise à jour de l'analyse • Jan 08
DXCO3: Future Margins And Stock Split Plan Will Support Upside
Analysts have adjusted their price target for Dexco, reflecting a fair value change from $9.83 to $8.81. This shift is tied to updated assumptions for revenue growth, profit margins and future P/E expectations.Article d'analyse • Dec 25
Dexco S.A. (BVMF:DXCO3) Not Flying Under The Radar
With a price-to-earnings (or "P/E") ratio of 41.1x Dexco S.A. ( BVMF:DXCO3 ) may be sending very bearish signals at the...Mise à jour de l'analyse • Dec 23
DXCO3: Stronger Future Margins And Investor Day May Drive Upside
Analysts have adjusted their price target on Dexco from R$10.00 to roughly R$9.83 per share. This reflects slightly lower revenue growth assumptions, stronger expected profit margins, and a more conservative future valuation multiple.Article d'analyse • Nov 13
Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. We think that...Article d'analyse • Oct 06
Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Mise à jour de l'analyse • Sep 06
Urbanization Trends And Digital Platforms Will Expand Market Reach
With both revenue growth and net profit margin forecasts holding steady, Dexco’s analyst consensus fair value remains unchanged at R$8.00. Valuation Changes Summary of Valuation Changes for Dexco The Consensus Analyst Price Target remained effectively unchanged, at R$8.00.Article d'analyse • Mar 21
Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think
A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. Our analysis...Article d'analyse • Mar 15
Dexco S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Shareholders might have noticed that Dexco S.A. ( BVMF:DXCO3 ) filed its full-year result this time last week. The...
Nouvelle analyse • Mar 10
New Ceramic Tiles Factory In Botucatu Will Improve Future Operations
Streamlining of operations could enhance focus on core areas, boosting profitability and improving net margins.Article d'analyse • Feb 12
Here's Why Dexco (BVMF:DXCO3) Has A Meaningful Debt Burden
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Article d'analyse • Dec 20
Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?
While Dexco S.A. ( BVMF:DXCO3 ) might not have the largest market cap around , it saw significant share price movement...Article d'analyse • Dec 02
There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price
When close to half the companies in Brazil have price-to-earnings ratios (or "P/E's") below 8x, you may consider Dexco...Article d'analyse • Oct 26
Is Dexco (BVMF:DXCO3) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Article d'analyse • Aug 10
Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results
Shareholders of Dexco S.A. ( BVMF:DXCO3 ) will be pleased this week, given that the stock price is up 12% to R$8.05...Article d'analyse • Aug 08
Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching
Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a decent share price growth of 14% on the...Article d'analyse • Jul 19
Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...Article d'analyse • May 13
Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts
Last week saw the newest quarterly earnings release from Dexco S.A. ( BVMF:DXCO3 ), an important milestone in the...Article d'analyse • May 04
Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?
Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a double-digit share price rise of over 10...Article d'analyse • Apr 15
Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Article d'analyse • Mar 14
Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem
Shareholders didn't seem to be thrilled with Dexco S.A.'s ( BVMF:DXCO3 ) recent earnings report, despite healthy profit...Article d'analyse • Jan 19
Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors
With a price-to-earnings (or "P/E") ratio of 7.5x Dexco S.A. ( BVMF:DXCO3 ) may be sending bullish signals at the...Article d'analyse • Jan 04
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Article d'analyse • Dec 04
At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?
Dexco S.A. ( BVMF:DXCO3 ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...Article d'analyse • Oct 08
Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Article d'analyse • Sep 13
Is Dexco (BVMF:DXCO3) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Article d'analyse • Jun 22
Returns At Dexco (BVMF:DXCO3) Are On The Way Up
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Rendement pour les actionnaires
| DXCO3 | BR Forestry | BR Marché | |
|---|---|---|---|
| 7D | 11.0% | 1.3% | -1.5% |
| 1Y | 23.8% | -11.4% | 20.3% |
Rendement vs Industrie: DXCO3 a dépassé le secteur BR Forestry qui a rapporté -11.4 % au cours de l'année écoulée.
Rendement vs marché: DXCO3 a dépassé le marché BR qui a rapporté 20.3 % au cours de l'année écoulée.
Volatilité des prix
| DXCO3 volatility | |
|---|---|
| DXCO3 Average Weekly Movement | 6.1% |
| Forestry Industry Average Movement | 5.1% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in BR Market | 8.3% |
| 10% least volatile stocks in BR Market | 1.7% |
Cours de l'action stable: DXCO3 n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché BR.
Volatilité au fil du temps: La volatilité hebdomadaire de DXCO3 ( 6% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1951 | n/a | Raul Guaragna | ri.dex.co |
Dexco S.A., avec ses filiales, produit et vend des panneaux de bois au Brésil et à l'étranger. Elle exerce ses activités dans les secteurs du bois, du déca et des revêtements. La société propose des panneaux à particules de densité moyenne et des panneaux à fibres de densité moyenne et élevée sous la marque Duratex ; des sols stratifiés et des composants semi-finis pour meubles sous la marque Durafloor ; et de la porcelaine vitrifiée, des accessoires de salle de bain en métal et des douches sous les marques Deca, Hydra, Belize, Elizabeth et Hydra Corona.
Dexco S.A. Résumé des fondamentaux
| DXCO3 statistiques fondamentales | |
|---|---|
| Capitalisation boursière | R$5.24b |
| Bénéfices(TTM) | R$1.18m |
| Recettes(TTM) | R$8.25b |
4,431x
Ratio P/E0.6x
Ratio P/SLe site DXCO3 est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| DXCO3 compte de résultat (TTM) | |
|---|---|
| Recettes | R$8.25b |
| Coût des recettes | R$6.35b |
| Marge brute | R$1.90b |
| Autres dépenses | R$1.90b |
| Les revenus | R$1.18m |
Derniers bénéfices déclarés
Dec 31, 2025
Prochaine date de publication des résultats
Aug 06, 2026
| Résultat par action (EPS) | 0.0013 |
| Marge brute | 23.04% |
| Marge bénéficiaire nette | 0.014% |
| Ratio dettes/capitaux propres | 111.7% |
Quelles ont été les performances à long terme de DXCO3?
Voir les performances historiques et les comparaisonsDividendes
3.3%
Rendement actuel des dividendesn/a
Ratio de distributionAnalyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/11 11:56 |
| Cours de l'action en fin de journée | 2026/05/08 00:00 |
| Les revenus | 2025/12/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Dexco S.A. est couverte par 16 analystes. 11 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Guilherme Rosito | BofA Global Research |
| Rafael Barcellos | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |
| Carlos Palhares Sequeira | BTG Pactual |